Skip to Content

Hydralazine Injection

Last Updated: November 30, 2011
Status: Resolved

Products Affected - Description

Hydralazine Injection

Reason for the Shortage

  • American Regent had temporarily suspended distribution of all drug products in April, 2011.
  • American Regent resumed manufacturing in Shirley, New York in early-May, 2011.
  • APP had hydralazine injection on shortage due to increased demand for the product.
  • Akorn had hydralazine injection on allocation to prevent hoarding.

Available Products

Hydralazine injection, Akorn
20 mg/mL, 1 mL vial (NDC 17478-0934-01)

Hydralazine injection, American Regent
20 mg/mL, 1 mL vial (NDC 00517-0901-25)

Hydralazine injection, APP
20 mg/mL, 1 mL vial (NDC 63323-0614-01)
20 mg/mL, 1 mL Novaplus vial (NDC 63323-0614-55)

Estimated Resupply Dates

All presentations are available.

Related Shortages

Updated

November 30, 2011; November 16, 2011; October 13, 2011; September 30, 2011; August 17, 2011; August 10, 2011; August 2, 2011; June 23, 2011; June 3, 2011; May 3, 2011; April 25, 2011; April 20, 2011, University of Utah, Drug Information Service. Copyright 2011, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide